PL1977244T3 - Rozróżnianie bakteryjnego i wirusowego zapalenia opon mózgowych - Google Patents

Rozróżnianie bakteryjnego i wirusowego zapalenia opon mózgowych

Info

Publication number: PL1977244T3
Authority: PL; Poland
Prior art keywords: meningitis; distinction; present; bacterial; procalcitonin
Prior art date: 2005-12-14

Application number

PL06841938T

Other languages

English (en)

Inventor

Martin Chalumeau

François Dubos

Dominique Gendrel

Gérard Breart

Original Assignee

Hopitaux Paris Assist Publique

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-14

Filing date

2006-12-14

Publication date

2011-02-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36218072&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1977244(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-12-14 Application filed by Hopitaux Paris Assist Publique filed Critical Hopitaux Paris Assist Publique

2011-02-28 Publication of PL1977244T3 publication Critical patent/PL1977244T3/pl

Links

206010027202 Meningitis bacterial Diseases 0.000 title abstract 4
201000009904 bacterial meningitis Diseases 0.000 title abstract 4
206010027260 Meningitis viral Diseases 0.000 title abstract 2
201000010044 viral meningitis Diseases 0.000 title abstract 2
108010048233 Procalcitonin Proteins 0.000 abstract 3
CWCXERYKLSEGEZ-KDKHKZEGSA-N procalcitonin Chemical compound C([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CSSC1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 CWCXERYKLSEGEZ-KDKHKZEGSA-N 0.000 abstract 3
108090000623 proteins and genes Proteins 0.000 abstract 3
102000004169 proteins and genes Human genes 0.000 abstract 3
210000001175 cerebrospinal fluid Anatomy 0.000 abstract 2
239000000523 sample Substances 0.000 abstract 2
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000013074 reference sample Substances 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56944—Streptococcus
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/106664—Blood serum or blood plasma standard or control

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Cell Biology (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Pathology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Physics & Mathematics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL06841938T 2005-12-14 2006-12-14 Rozróżnianie bakteryjnego i wirusowego zapalenia opon mózgowych PL1977244T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0512687A FR2894675B1 (fr)	2005-12-14	2005-12-14	Distinction des meningites bacteriennes et virales
EP06841938A EP1977244B1 (fr)	2005-12-14	2006-12-14	Distinction des meningites bacteriennes et virales
PCT/FR2006/002734 WO2007068830A1 (fr)	2005-12-14	2006-12-14	Distinction des meningites bacteriennes et virales

Publications (1)

Publication Number	Publication Date
PL1977244T3 true PL1977244T3 (pl)	2011-02-28

Family

ID=36218072

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL06841938T PL1977244T3 (pl)	2005-12-14	2006-12-14	Rozróżnianie bakteryjnego i wirusowego zapalenia opon mózgowych

Country Status (11)

Country	Link
US (1)	US8232046B2 (pl)
EP (1)	EP1977244B1 (pl)
AT (1)	ATE475096T1 (pl)
CA (1)	CA2633912A1 (pl)
DE (1)	DE602006015702D1 (pl)
ES (1)	ES2352045T3 (pl)
FR (1)	FR2894675B1 (pl)
PL (1)	PL1977244T3 (pl)
PT (1)	PT1977244E (pl)
SI (1)	SI1977244T1 (pl)
WO (1)	WO2007068830A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2894675B1 (fr)	2005-12-14	2008-06-27	Assist Publ Hopitaux De Paris	Distinction des meningites bacteriennes et virales
GB0711327D0 (en)	2007-06-12	2007-07-25	Hansa Medical Ab	Diagnostic method
PT2419741T (pt) *	2009-04-14	2019-11-04	Brahms Gmbh	Avaliação de risco para tratamento com antibióticos em pacientes que sofrem de doença não infeciosa primária através da determinação do nível de procalcitonina
WO2011110565A1 (en) *	2010-03-08	2011-09-15	B.R.A.H.M.S Gmbh	Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints
GB201016161D0 (en)	2010-09-24	2010-11-10	Hansa Medical Ab	Diagnostic method
GB201102108D0 (en)	2011-02-07	2011-03-23	Hansa Medical Ab	Diagnostic method
GB201518597D0 (en) *	2015-10-20	2015-12-02	Univ Liverpool	Detection of bacterial infection
CN115859174A (zh) *	2023-01-06	2023-03-28	深圳市儿童医院	一种细菌性脑膜炎分类模型构建方法及其在识别脑脊液宏基因组测序假阳性结果中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR512687A (fr)	1919-09-22	1921-01-28	Eugene Carlet De La Roziere	Bandage élastique pour roues de véhicules
JP2955082B2 (ja) *	1991-10-11	1999-10-04	大阪瓦斯株式会社	ヒトカルシトニンのｎ末端部分を特異的に認識するモノクローナル抗体
EP1063537A3 (de)	1995-11-24	2005-09-14	Swissray International Inc.	Optische Anordnung und Verfahren zum elektronischen Erfassen eines Röntgenbilds
JP4037933B2 (ja) *	1996-12-24	2008-01-23	大阪瓦斯株式会社	抗ヒトカルシトニンモノクローナル抗体
DE50015156D1 (de) *	1999-12-22	2008-06-26	Dade Behring Marburg Gmbh	Gegen Procalcitonin gerichtete Antikörper, ihre Herstellung und Verwendung
DE50014159D1 (de)	1999-12-22	2007-04-26	Dade Behring Marburg Gmbh	Lösungen von humanem Procalcitonin
FR2894675B1 (fr)	2005-12-14	2008-06-27	Assist Publ Hopitaux De Paris	Distinction des meningites bacteriennes et virales

2005
- 2005-12-14 FR FR0512687A patent/FR2894675B1/fr not_active Expired - Fee Related
2006
- 2006-12-14 DE DE602006015702T patent/DE602006015702D1/de active Active
- 2006-12-14 ES ES06841938T patent/ES2352045T3/es active Active
- 2006-12-14 CA CA002633912A patent/CA2633912A1/fr not_active Abandoned
- 2006-12-14 AT AT06841938T patent/ATE475096T1/de active
- 2006-12-14 EP EP06841938A patent/EP1977244B1/fr not_active Revoked
- 2006-12-14 PL PL06841938T patent/PL1977244T3/pl unknown
- 2006-12-14 US US12/097,711 patent/US8232046B2/en not_active Expired - Fee Related
- 2006-12-14 WO PCT/FR2006/002734 patent/WO2007068830A1/fr not_active Ceased
- 2006-12-14 PT PT06841938T patent/PT1977244E/pt unknown
- 2006-12-14 SI SI200630850T patent/SI1977244T1/sl unknown

Also Published As

Publication number	Publication date
PT1977244E (pt)	2010-11-11
US20090221021A1 (en)	2009-09-03
US8232046B2 (en)	2012-07-31
EP1977244B1 (fr)	2010-07-21
ES2352045T3 (es)	2011-02-15
CA2633912A1 (fr)	2007-06-21
FR2894675B1 (fr)	2008-06-27
ATE475096T1 (de)	2010-08-15
SI1977244T1 (sl)	2011-02-28
FR2894675A1 (fr)	2007-06-15
EP1977244A1 (fr)	2008-10-08
WO2007068830A1 (fr)	2007-06-21
DE602006015702D1 (de)	2010-09-02

Publication	Publication Date	Title
ATE538386T1 (de)	2012-01-15	Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
ATE289685T1 (de)	2005-03-15	Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
WO2003043487A3 (en)	2003-09-25	Method of using a non-antibody protein to detect and measure an analyte
ATE425266T1 (de)	2009-03-15	Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
PL2073008T3 (pl)	2012-09-28	Ulepszone sposoby prowadzenia testów immunologicznych
WO2008021290A8 (en)	2008-04-17	Organ-specific proteins and methods of their use
WO2008134526A3 (en)	2008-12-31	Glycoprotein profiling of bladder cancer
MY145455A (en)	2012-02-15	Diagnostic biomolecule(s)
TW200720441A (en)	2007-06-01	New labelling strategies for the sensitive detection of analytes
PL1776587T3 (pl)	2009-06-30	Zastosowanie C3A i jego pochodnych jako biomarkera do leczenia gruczolaka i/lub raka jelita grubego; metody diagnostyczne i testy z ich użyciem
WO2004057336A3 (en)	2005-01-20	Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
WO2007149065A3 (en)	2008-09-25	Methods and apparatuses for detecting chemical or biological agents
SI1977244T1 (sl)	2011-02-28	Razlikovanje med bakterijskim meningitisom in virusnim meningitisom
WO2008131261A3 (en)	2009-01-29	Peptide biomarkers of cardiovascular disease
WO2011109112A3 (en)	2011-10-27	Method of detecting tau protein and tau fragments in serum
WO2007030949A3 (en)	2007-05-03	Methods of diagnosing ovarian cancer and kits therefor
WO2005124356A3 (en)	2006-05-04	Use of protein cbp2 as a marker for colorectal cancer
GB2437545B (en)	2011-07-06	Dextrin-containing reagents for detecting and quantifying proteins
WO2002057793A3 (en)	2003-03-06	Method of detecting prp protein and kits therefor
ATE383418T1 (de)	2008-01-15	Verfahren und zusammensetzungen zur bestimmung glycierter proteine
ATE534037T1 (de)	2011-12-15	Verwendung des proteins asc als marker für brustkrebs
ATE412181T1 (de)	2008-11-15	Verbessertes verfahren zur diagnose des akuten koronarsyndroms
DE602005013430D1 (de)	2009-04-30	Verwendung von asc als marker für kolorektalkarzinome
TW200502399A (en)	2005-01-16	Recombinant virus and use thereof and method of detecting an analyte in a sample and kit thereof
ATE393393T1 (de)	2008-05-15	Verwendung des proteins spee als marker für brustkrebs